Complications in Patients with Myasthenia Gravis Treated with Oral Corticosteroids (P4-8.007)
To describe the association between oral corticosteroid (OCS) use and related adverse effects (AEs) among myasthenia gravis (MG) patients.
Authors
- Zia Choudhry
- Jacqueline A. Pesa (ORCID: https://orcid.org/0000-0002-8335-3009)
- Zhiwen Liu (ORCID: https://orcid.org/0000-0002-0743-4237)
- Nizar Souayah (ORCID: https://orcid.org/0000-0003-3873-3448)
- Alicia Campbell
- Louis Jackson (ORCID: https://orcid.org/0009-0008-9547-7501)
Institutions
- Johnson & Johnson (United States) (US)
- Janssen (Belgium) (BE)
- Rutgers Sexual and Reproductive Health and Rights (NL)
- Janssen Scientific Affairs (United States)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211386
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00